Edition:
United States

Invion Ltd (IVX.AX)

IVX.AX on Australia Stock Exchange

0.00AUD
24 Apr 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.00
Open
$0.00
Day's High
$0.00
Day's Low
$0.00
Volume
170,000
Avg. Vol
999,042
52-wk High
$0.01
52-wk Low
$0.00

IVX.AX

Chart for IVX.AX

About

Invion Limited is a clinical-stage life sciences (drug development) company. The Company is engaged in the completion of clinical development programs and targeted business development programs associated with its approximately three drug assets, such as INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast). It focuses... (more)
No analyst recommendations are available for IVX.AX.

Overall

Beta: 1.99
Market Cap(Mil.): $4.95
Shares Outstanding(Mil.): 1,237.07
Dividend: --
Yield (%): --

Financials

  IVX.AX Industry Sector
P/E (TTM): 3.25 57.54 29.95
EPS (TTM): 0.00 -- --
ROI: 14.75 -0.41 13.21
ROE: 18.97 6.21 14.38

BRIEF-Invion Ltd anounces strategic alliance with The Cho Group

* cho group will make an equity investment via placement of 17.69% of existing shares

Apr 17 2017

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.